Georgia's Online Cancer Information Center

Emory, Metaclipse Therapeutics get $2.4 million grant for breast cancer vaccine

7/21/2016, Ellie Hensley, Atlanta Business Chronicle

A team of Emory University and Atlanta-based Metaclipse Therapeutics Corp. researchers landed a $2.4 million grant from the National Institutes of Health and National Cancer Institute.

The five-year grant will be used to develop new cancer vaccine immunotherapies for patients with triple-negative breast cancer (TNBC).

A team of Emory University and Atlanta-based Metaclipse Therapeutics Corp. researchers landed a $2.4 million grant from the National Institutes of Health and National Cancer Institute. The five-year grant will be used to develop new cancer vaccine immunotherapies for patients with triple-negative breast cancer (TNBC).

TBNC is very hard to treat because it doesn't present any defined targets for drugs or vaccines to attack, and five-year survival rates are lower for it than other types of breast cancer. The disease is more common in young African-American women.

The researchers are developing a vaccine using tumor membrane vesicles derived from the patient's own tumor.

NIH previously gave Metaclipse a grant to study the vaccine technology in a mouse model of TNBC. It has also received grants from the Georgia Research Alliance Venture Lab program and the Coulter Foundation.

Now Metaclipse and Emory will use a new mouse model that more closely mimics the human immune system. Researchers will use both mouse tumor tissue and human TNBC tissue to compare standard-of-care chemotherapy treatments alone versus those combined with the vaccine they are testing.

Co-principal investigators for the study are Periasamy Selvaraj, Emory professor of pathology and laboratory medicine and Winship Cancer Institute member, and Christopher Pack, director of preclinical research at Metaclipse Therapeutics.

Ellie Hensley is an entertainment, health care and general assignment reporter.

To read the original article on the Atlanta Business Chronicle website, click here.

Media, News & Events

Greetings of gratitude from our president and CEO

Lynn gives a message of thanks and a glimpse into what's to come in 2022.

11/18/2021

Cancer Center opens in Braselton

“This new collaborative space puts our patients’ needs front and center by providing a more cohesive environment with access to both medical oncology/hematology and radiation oncology services within steps of each other,” says Charles Nash III, MD, FACP, medical director of NGMC’s Cancer Services and medical oncologist with Longstreet Clinic (and Georgia CORE Board member).

6/29/2021

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.